JNJ-64264681
oral BTK inhibitor Ph. I candidate in NHL/CLL patients from Janssen cmp. collection screen and opt. J. Med. Chem. Janssen, San Diego, CA
Molecules of the Month - October 2022
oral BTK inhibitor Ph. I candidate in NHL/CLL patients from Janssen cmp. collection screen and opt. J. Med. Chem. Janssen, San Diego, CA
Molecules of the Month - October 2022